Adrienn Volak

1.3k total citations · 1 hit paper
9 papers, 954 citations indexed

About

Adrienn Volak is a scholar working on Molecular Biology, Genetics and Cognitive Neuroscience. According to data from OpenAlex, Adrienn Volak has authored 9 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Genetics and 2 papers in Cognitive Neuroscience. Recurrent topics in Adrienn Volak's work include Virus-based gene therapy research (5 papers), RNA regulation and disease (3 papers) and RNA Interference and Gene Delivery (3 papers). Adrienn Volak is often cited by papers focused on Virus-based gene therapy research (5 papers), RNA regulation and disease (3 papers) and RNA Interference and Gene Delivery (3 papers). Adrienn Volak collaborates with scholars based in United States, France and Switzerland. Adrienn Volak's co-authors include Casey A. Maguire, Bence György, Xandra O. Breakefield, David P. Corey, Benjamin P. Kleinstiver, Killian S. Hanlon, Mikołaj Piotr Zaborowski, Martin Ingelsson, J. Keith Joung and Camilla Lööv and has published in prestigious journals such as Nature Communications, Scientific Reports and Human Molecular Genetics.

In The Last Decade

Adrienn Volak

9 papers receiving 944 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High levels of AAV vector integration into CRISPR-induced DNA breaks

2019 289 citations Killian S. Hanlon, Benjamin P. Kleinstiver et al. Nature Communications profile →

Peers

Countries citing papers authored by Adrienn Volak

Since Specialization

Citations

This map shows the geographic impact of Adrienn Volak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrienn Volak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrienn Volak more than expected).

Fields of papers citing papers by Adrienn Volak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrienn Volak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrienn Volak. The network helps show where Adrienn Volak may publish in the future.

Co-authorship network of co-authors of Adrienn Volak

This figure shows the co-authorship network connecting the top 25 collaborators of Adrienn Volak. A scholar is included among the top collaborators of Adrienn Volak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrienn Volak. Adrienn Volak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	In vivo engineering of lymphocytes after systemic exosome-associated AAV delivery 2020 ·Scientific Reports ·(unknown), Killian S. Hanlon, (unknown), Adrienn Volak, Amine Meliani, Federico Mingozzi, Benjamin P. Kleinstiver, James J. Moon, Casey A. Maguire	25
2	Gene therapy for Alzheimer’s disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation 2020 ·Human Molecular Genetics ·Ana Griciuc, Anthony Federico, (unknown), (unknown), D. McGinty, (unknown), Adrienn Volak, Stanley G. LeRoy, (unknown), Paul Lerner, Eloïse Hudry, Rudolph E. Tanzi, Casey A. Maguire	89
3	High levels of AAV vector integration into CRISPR-induced DNA breaks breakdown → 2019 ·Nature Communications ·Killian S. Hanlon, Benjamin P. Kleinstiver, Sara P. Garcia, Mikołaj Piotr Zaborowski, Adrienn Volak, (unknown), (unknown), Alexander A. Sousa, Shengdar Q. Tsai, Niclas E. Bengtsson, Camilla Lööv, Martin Ingelsson, Jeffrey S. Chamberlain, David P. Corey, Martin J. Aryee, J. Keith Joung, Xandra O. Breakefield, Casey A. Maguire, Bence György	289
4	Gene Transfer with AAV9-PHP.B Rescues Hearing in a Mouse Model of Usher Syndrome 3A and Transduces Hair Cells in a Non-human Primate 2018 ·Molecular Therapy — Methods & Clinical Development ·Bence György, (unknown), Maryna V. Ivanchenko, (unknown), (unknown), Killian S. Hanlon, Artur A. Indzhykulian, Adrienn Volak, K. Domenica Karavitaki, (unknown), Mark Vézina, V. K. Berezovskii, Richard T. Born, Maureen T. O’Brien, J. Lafond, Yvan Arsenijévic, Margaret A. Kenna, Casey A. Maguire, David P. Corey	125
5	Efficient Gene Transfer to the Central Nervous System by Single-Stranded Anc80L65 2018 ·Molecular Therapy — Methods & Clinical Development ·Eloïse Hudry, Eva Andrés‐Mateos, Paul Lerner, Adrienn Volak, (unknown), Bradley T. Hyman, Casey A. Maguire, Luk H. Vandenberghe	65
6	Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous delivery 2018 ·Journal of Neuro-Oncology ·Adrienn Volak, Stanley G. LeRoy, (unknown), Jae‐Hyun Park, Pike-See Cheah, (unknown), Zachary Fitzpatrick, Eloïse Hudry, (unknown), (unknown), Bradley T. Hyman, Dakai Mu, (unknown), Anat Stemmer‐Rachamimov, Miguel Sena‐Esteves, Christian E. Badr, Casey A. Maguire	23
7	CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer’s Disease 2018 ·Molecular Therapy — Nucleic Acids ·Bence György, Camilla Lööv, Mikołaj Piotr Zaborowski, Shuko Takeda, Benjamin P. Kleinstiver, Caitlin Commins, Ksenia V. Kastanenka, Dakai Mu, Adrienn Volak, Vilmantas Giedraitis, Lars Lannfelt, Casey A. Maguire, J. Keith Joung, Bradley T. Hyman, Xandra O. Breakefield, Martin Ingelsson	128
8	Intrathecal Adeno-Associated Viral Vector-Mediated Gene Delivery for Adrenomyeloneuropathy 2018 ·Human Gene Therapy ·Yi Gong, (unknown), (unknown), Guangping Gao, Dan Wang, Carrie Ng, Adrienn Volak, René Kok, (unknown), Inge M. E. Dijkstra, Stephan Kemp, Casey A. Maguire, Florian Eichler	28
9	Rescue of Hearing by Gene Delivery to Inner-Ear Hair Cells Using Exosome-Associated AAV 2017 ·Molecular Therapy ·Bence György, Cyrille Sage, Artur A. Indzhykulian, Déborah Scheffer, Alain Brisson, Sisareuth Tan, Xudong Wu, Adrienn Volak, Dakai Mu, (unknown), Yaqiao Li, Zachary Fitzpatrick, Maria Ericsson, Xandra O. Breakefield, David P. Corey, Casey A. Maguire	182

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact